Peptide Therapy for Beginners: What to Know Before Your First Visit

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Peptide therapy should only be pursued under the supervision of a qualified healthcare provider. Individual results vary. Consult your doctor before starting any new treatment.

Affiliate Disclosure: Peptide Front may earn a commission from products linked in this article. This does not influence our editorial coverage or recommendations.

What Is Peptide Therapy and Why Is It Gaining Traction?

Peptide therapy involves administering short chains of amino acids — typically between 2 and 50 amino acids long — to trigger specific biological responses in the body. Unlike traditional pharmaceuticals that often work by blocking or inhibiting processes, most therapeutic peptides work by mimicking or amplifying signals your body already uses. Think of them as targeted biological instructions.

The Science Behind Peptides

Your body produces thousands of peptides naturally. Insulin is a peptide. So are the endorphins that flood your brain after a hard workout. Therapeutic peptides are either synthetic copies of these natural signaling molecules or modified versions designed for better stability and absorption.

The mechanism varies by peptide. Growth hormone secretagogues like CJC-1295 stimulate your pituitary gland to release more of its own growth hormone. Healing peptides like BPC-157 accelerate tissue repair by upregulating growth factor receptors. Copper peptides like GHK-Cu promote collagen synthesis and wound healing at the cellular level.

A 2023 review published in Molecules identified over 80 FDA-approved peptide therapeutics on the global market, with approximately 170 more in active clinical trials (Muttenthaler et al., Chemical Reviews, 2021). The global peptide therapeutics market reached $49.3 billion in 2024 and is projected to exceed $68 billion by 2028, according to Grand View Research — reflecting both clinical validation and surging consumer demand.

Why the Sudden Popularity

Peptide therapy isn't new. Insulin has been used since 1922. But three factors drove the recent explosion in interest.

First, social media. Influencers and biohackers started sharing their experiences with peptides like BPC-157 for injury recovery and Ipamorelin for body composition, creating massive grassroots awareness. Second, the GLP-1 revolution. Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) — both peptide drugs — became household names for weight loss, putting the entire category in the spotlight. Third, accessibility expanded. Telehealth peptide clinics proliferated during and after COVID, making it possible to get a prescription and compounded peptides shipped to your door.

But popularity also attracted bad actors. The FDA reported a significant uptick in adverse events from contaminated, unregulated peptide products sold online between 2023 and 2025. That's why understanding the landscape before your first visit matters so much.

Who Is Peptide Therapy For?

Peptide therapy isn't a magic bullet, and it's not for everyone. The strongest clinical evidence supports its use for:

Growth hormone deficiency — FDA-approved peptides like sermorelin and tesamorelin have decades of safety data
Weight management — GLP-1 agonists produce measurable weight loss within 2-4 weeks, with studies showing 15-20% body weight reduction over 68 weeks (Wilding et al., NEJM, 2021)
Tissue repair and recovery — BPC-157 and TB-500 are widely used for tendon, ligament, and muscle injuries, though most evidence comes from animal studies
Skin health and anti-aging — GHK-Cu has peer-reviewed evidence for wound healing and collagen stimulation (Pickart et al., International Journal of Molecular Sciences, 2015)
Sexual health — PT-141 (Bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women

If you're generally healthy and just curious, a provider can help you determine whether peptide therapy addresses a genuine clinical need or if you'd be better served by other interventions first.

The Regulatory Landscape: What Changed in 2026

Understanding the regulatory environment isn't optional — it directly affects which peptides you can legally access, where you get them, and how safe they are.

The 2023 Crackdown and Its Fallout

In September 2023, the FDA placed 19 popular peptides on its "difficult to compound" list, effectively banning compounding pharmacies from producing them. The list included BPC-157, TB-500, and several growth hormone secretagogues. The reasoning: these peptides lacked sufficient safety data and standardized compounding processes.

The decision sent shockwaves through the peptide therapy community. Patients who had been using compounds like BPC-157 for chronic pain or injury recovery suddenly lost access through legal channels. Some turned to gray-market research chemical suppliers — which is exactly the outcome the FDA hoped to prevent.

Clinicians pushed back hard. Multiple medical organizations argued that the blanket ban ignored decades of clinical use and forced patients toward less safe alternatives.

The February 2026 Reversal

On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced a major reversal. Approximately 14 of the 19 previously restricted peptides were reclassified back to Category 1, restoring legal compounding status. The reinstated peptides included BPC-157, TB-500, Thymosin Alpha-1, Ipamorelin, Selank, Semax, and GHK-Cu.

This was a significant win for patient access, but it came with guardrails. Compounding pharmacies producing these peptides must still:

Hold a valid state license
Operate under a prescriber's order (503A) or FDA registration (503B)
Follow Current Good Manufacturing Practices (cGMP) or USP <797> standards
Provide Certificates of Analysis (COA) for each batch

The reclassification doesn't mean these peptides are FDA-approved drugs. It means licensed pharmacies can legally compound them again under physician supervision. There's a meaningful distinction, and it matters for your safety.

What's Still Restricted

Not all 19 peptides came back. Some remain on the restricted list or exist in regulatory gray areas. Before your first visit, know that the regulatory landscape is still evolving. Your provider should be able to tell you exactly which peptides they can legally prescribe and compound as of your appointment date. If they can't — or won't — answer that question clearly, find a different provider.

For a deeper comparison of how different peptide categories work, see our guide on CJC-1295 vs Sermorelin: Growth Hormone Secretagogues Compared.

How to Find a Qualified Peptide Therapy Provider

This is where most beginners go wrong. The provider you choose determines everything — the quality of your assessment, the legitimacy of your prescription, the safety of your peptides, and whether you're actually a good candidate in the first place.

What Credentials to Look For

Peptide therapy isn't a recognized medical specialty with its own board certification. Providers come from various backgrounds: anti-aging medicine, functional medicine, endocrinology, sports medicine, naturopathic medicine (in states that grant prescriptive authority), and general practice.

Look for:

Medical license — MD, DO, NP, or PA with active, unrestricted licensure in your state
Specialized training — Certifications from organizations like the American Academy of Anti-Aging Medicine (A4M), the Institute for Functional Medicine (IFM), or peptide-specific continuing education
Experience — Ask how many patients they've treated with peptides and for how long. A provider who started prescribing peptides last month after a weekend seminar is different from one with five years of clinical experience
Pharmacy relationships — Reputable providers work with specific compounding pharmacies they've vetted. They should name the pharmacy and explain why they use it

Red Flags That Should Send You Running

The peptide therapy space attracts practitioners who prioritize revenue over patient safety. Watch for:

No lab work required — Any provider who prescribes peptides without baseline bloodwork is cutting corners. Period. You need at minimum a comprehensive metabolic panel, hormone levels, and often IGF-1 and inflammatory markers
Guaranteed results — Peptide therapy outcomes vary significantly between individuals. Anyone promising specific results is selling, not treating
Only sells their own peptides — Some clinics mark up peptide prices by 200-400% above acquisition cost. A provider who won't let you use an outside pharmacy is likely profiting heavily from the dispensing side
No follow-up protocol — Peptide therapy requires monitoring. If there's no plan for follow-up labs and check-ins, the provider isn't managing your care
Pressure to start immediately — A good provider will review your labs, discuss options, and give you time to decide. High-pressure sales tactics belong at car dealerships, not medical offices

Telehealth vs In-Person Visits

Telehealth peptide clinics exploded during COVID and remain popular. They offer convenience and often lower consultation costs. But there are trade-offs.

In-person visits allow for physical examination, which matters if you're seeking peptide therapy for a specific injury or condition. They also tend to involve more thorough initial assessments. Telehealth visits work well for straightforward use cases — general wellness optimization, body composition, or continuing a protocol you've already started with another provider.

Regardless of format, the same credential and quality standards apply. A telehealth provider should still require labs, review your medical history in detail, and have a follow-up plan.

What to Expect at Your First Appointment

Walking into your first peptide therapy appointment (or logging into your first telehealth call) shouldn't feel like a mystery. Here's what a thorough initial visit looks like.

Pre-Appointment Preparation

Before your appointment, most reputable providers will ask you to:

Complete a detailed health questionnaire covering medical history, current medications, supplements, allergies, prior surgeries, and family history
Get baseline bloodwork — some clinics have their own lab orders, others accept recent results from your primary care provider. Typical panels include CBC, CMP, lipid panel, thyroid function, testosterone (total and free), estradiol, IGF-1, fasting insulin, and inflammatory markers like CRP and ESR
List your goals — be specific. "I want to feel better" is less useful than "I have a partial rotator cuff tear that hasn't responded to physical therapy" or "My IGF-1 is in the bottom 10th percentile for my age and I'm experiencing poor recovery from training"

Bring copies of any relevant imaging (MRIs, X-rays) if you're pursuing peptide therapy for an injury. Bring a list of every medication and supplement you take, including doses.

The Consultation Process

A quality initial consultation typically runs 30-60 minutes and covers:

Medical history review. The provider should ask about your health history in detail, not just glance at your questionnaire. They're looking for contraindications — reasons peptide therapy might be unsafe for you. Active cancer, for example, is a contraindication for growth hormone secretagogues because GH can promote tumor growth.

Lab review. Your bloodwork tells the story. A knowledgeable provider will walk you through your results and explain how they inform peptide selection. Low IGF-1 might point toward a growth hormone secretagogue. Elevated inflammatory markers might suggest BPC-157 or Thymosin Alpha-1. They should explain the rationale, not just hand you a prescription.

Treatment plan discussion. Based on your history, labs, and goals, the provider will recommend specific peptides, dosing protocols, and administration routes. This is where you should ask questions:

Why this specific peptide over alternatives?
What does the clinical evidence show?
What are the potential side effects?
How long before I should expect to notice effects?
What does the monitoring schedule look like?

Administration training. If your protocol involves injectable peptides (many do), you'll receive instruction on reconstitution, dosing, injection technique, and proper storage. Subcutaneous injections use small insulin-type needles and are relatively painless — most patients describe it as less uncomfortable than a mosquito bite once they get the technique down.

Common First-Visit Protocols

While every protocol is individualized, some common starting points for beginners include:

Recovery and healing: BPC-157 at 250-500 mcg/day, subcutaneous, often paired with TB-500 for synergistic effects
Growth hormone optimization: CJC-1295 with Ipamorelin, typically dosed before bed to align with natural GH pulsatility
Skin and anti-aging: GHK-Cu topically or subcutaneously, sometimes combined with a GH secretagogue
Sexual health: PT-141 (Bremelanotide), dosed as needed approximately 45 minutes before sexual activity

Your provider might start with a single peptide to establish your tolerance and response before adding anything else. This is smart practice. Stacking multiple peptides from day one makes it harder to identify what's working and what might be causing side effects.

For a comparison of delivery methods, check out Oral Peptides vs Injectable: Bioavailability and Cost.

Understanding Costs: What Peptide Therapy Actually Runs

Money matters. Peptide therapy is an out-of-pocket expense for most people, so you need a clear picture before committing.

Consultation Fees

Initial consultations typically range from $200-$500 depending on the provider, location, and whether it's in-person or telehealth. Some clinics offer lower initial consultation fees ($99-$150) but build costs into the peptide pricing. Others charge premium consultation fees ($400-$500) but offer peptides at closer to cost.

Follow-up visits usually run $75-$200 and should occur every 4-8 weeks during the initial phase, then every 3-6 months once your protocol is established.

Peptide Costs

This is where pricing gets complicated. The same peptide can cost dramatically different amounts depending on the source:

Peptide	Monthly Cost Range	Notes
BPC-157	$150-$400/month	Price varies by dose and pharmacy
CJC-1295/Ipamorelin	$200-$500/month	Often sold as a combo
TB-500	$150-$350/month	Loading phase may cost more
GHK-Cu	$100-$300/month	Topical formulations tend to cost less
PT-141	$50-$200/month	As-needed dosing keeps costs variable
Sermorelin	$200-$450/month	One of the longer-established compounds

Some clinics mark up peptide prices by 200-400% above their acquisition cost from compounding pharmacies. Others operate on thinner margins and charge separately for consultations and management fees. Ask your provider to break down the costs so you understand what you're paying for.

Lab Work

Baseline labs can run $200-$600 out of pocket if ordered through the clinic. However, many providers will order labs through your insurance if possible, or you can use direct-to-consumer lab services like Quest or Labcorp's self-pay options for significant savings. Follow-up labs every 3-6 months add ongoing costs of $100-$300 per round.

Total First-Year Budget

For a realistic first-year estimate on a single-peptide protocol:

Initial consultation: $200-$500
Peptides (12 months): $1,800-$6,000
Lab work (baseline + 2-3 follow-ups): $400-$1,200
Follow-up visits (4-6): $300-$1,200

Total range: approximately $2,700-$8,900 for the first year, depending on the peptide, provider, and monitoring frequency.

That's a meaningful investment. It's worth asking whether the same goals could be achieved through lifestyle optimization first — sleep, nutrition, exercise, and stress management address many of the same systems peptides target.

Insurance and Payment Options

As of 2026, insurance rarely covers compounded peptides. FDA-approved peptide drugs like semaglutide, tesamorelin, or Bremelanotide (PT-141 under the brand name Vyleesi) may be covered depending on your plan and diagnosis. But compounded formulations from 503A or 503B pharmacies are almost universally out-of-pocket.

Some clinics offer payment plans or membership models that bundle consultations, labs, and peptides into a monthly fee ($300-$800/month). These can simplify budgeting but make sure you understand what happens if you want to stop or switch peptides mid-cycle.

Administration Methods: Injections, Creams, Orals, and Nasal Sprays

How you take your peptides matters as much as which peptides you take. Different administration routes offer different bioavailability, convenience, and cost profiles.

Subcutaneous Injections

The gold standard for most therapeutic peptides. Subcutaneous (subQ) injections deliver peptides directly into the fatty tissue just beneath the skin, bypassing the digestive system entirely. Bioavailability is typically 65-95% depending on the peptide.

The injection process is straightforward:

Reconstitution — Most peptides ship as lyophilized (freeze-dried) powder. You add bacteriostatic water to the vial, swirl gently (never shake), and refrigerate
Drawing the dose — Using an insulin syringe, draw the prescribed volume from the vial
Injection — Common sites include the abdominal fat pad (2 inches from the navel), thigh, or upper arm. Rotate sites to prevent tissue irritation
Storage — Reconstituted peptides must be refrigerated and are typically stable for 3-4 weeks

Most patients report minimal discomfort after the first few injections. The needles are small (29-31 gauge) and short (½ inch). The psychological barrier of self-injection is usually bigger than the physical discomfort.

Topical Applications

Some peptides — particularly GHK-Cu — are available in topical creams, serums, and patches. Topical delivery works best for localized effects (skin rejuvenation, wound healing) but has limited systemic bioavailability. If you're using GHK-Cu for general anti-aging benefits rather than targeted skin repair, your provider may recommend subcutaneous injection instead.

Oral Peptides

Oral peptide delivery has historically been challenging because stomach acid and digestive enzymes break down peptide bonds before they reach the bloodstream. Bioavailability for most oral peptides is below 5%, meaning you'd need significantly higher doses to achieve the same effect as an injection.

That said, oral peptide technology is advancing rapidly. BPC-157 was originally studied orally for gut healing (which makes sense — it doesn't need to survive digestion if the target is the digestive tract itself). And newer encapsulation technologies are improving oral bioavailability for some compounds.

For a detailed breakdown of how oral and injectable bioavailability compare across different peptides, see Oral Peptides vs Injectable: Bioavailability and Cost.

Nasal Sprays

Nasal delivery offers decent bioavailability (10-30%) for certain peptides, particularly smaller ones that can cross the nasal mucosa. Selank and Semax are commonly administered this way. PT-141 was originally studied as a nasal spray before its FDA-approved formulation (Vyleesi) went with subcutaneous injection.

Nasal sprays are convenient and needle-free but less precise in dosing and not suitable for all peptides.

Safety, Side Effects, and What the Research Actually Shows

Here's where you need honest information, not marketing copy.

What the Clinical Evidence Supports

The evidence base for therapeutic peptides varies enormously by compound:

Strong clinical evidence (FDA-approved, large trials):

GLP-1 agonists (semaglutide, tirzepatide) for weight management and type 2 diabetes — multiple phase III trials with thousands of participants
Tesamorelin for HIV-associated lipodystrophy — FDA-approved since 2010
PT-141 (Bremelanotide/Vyleesi) for hypoactive sexual desire disorder — FDA-approved in 2019 based on two phase III trials involving over 1,200 women (Kingsberg et al., Obstetrics & Gynecology, 2019)
Sermorelin for growth hormone deficiency — decades of clinical use

Moderate evidence (animal studies, small human trials, clinical use data):

BPC-157 — extensive animal data showing accelerated healing of tendons, ligaments, muscle, and gut tissue. Human trial data is limited but a phase II trial for ulcerative colitis showed promising results. Most clinical confidence comes from decades of off-label use by sports medicine physicians
CJC-1295/Ipamorelin — shown to increase GH and IGF-1 levels in human studies (Teichman et al., Journal of Clinical Endocrinology & Metabolism, 2006), but long-term safety data is limited
TB-500 — primarily animal data, particularly in horses, showing accelerated wound healing and reduced inflammation
GHK-Cu — peer-reviewed evidence for wound healing, collagen synthesis, and anti-inflammatory effects (Pickart et al., 2015), though most studies are in vitro or small-scale

Limited evidence:

Many newer or niche peptides have only preclinical data or anecdotal clinical reports

Common Side Effects

Most therapeutic peptides have relatively mild side effect profiles when properly dosed. Common side effects include:

Injection site reactions — redness, swelling, or itching at the injection site. Usually mild and transient
Water retention — particularly with growth hormone secretagogues. Often noticeable as mild hand or foot swelling in the first 2-4 weeks, usually self-resolving
Increased hunger or decreased appetite — depending on the peptide. GH secretagogues can increase appetite; GLP-1 agonists suppress it
Fatigue or lethargy — some patients report initial fatigue when starting GH secretagogues, possibly related to improved sleep depth
Flushing — particularly with PT-141, which can cause facial flushing and nausea in some patients
Headache — reported across multiple peptide categories, usually in the first week

Serious Risks and Contraindications

Serious adverse events from pharmaceutical-grade, properly administered peptides are uncommon. But they exist:

Growth hormone secretagogues should not be used by anyone with active cancer or a history of cancer, as elevated GH/IGF-1 can promote tumor growth. A study in The Lancet Diabetes & Endocrinology (2014) found an association between high IGF-1 levels and increased cancer risk
Contamination risk from unregulated sources — the FDA has documented cases of severe injection site infections, systemic infections, and sepsis from contaminated peptides purchased from unregulated online vendors. A 2024 analysis found that many research-grade BPC-157 products contained incorrect amino acid sequences, contamination, or significantly less active compound than labeled
Drug interactions — peptides can interact with existing medications. GH secretagogues may affect insulin sensitivity. PT-141 can cause blood pressure changes. Always disclose your full medication list

The Source Quality Problem

This is perhaps the most critical safety issue for beginners to understand. Not all peptides are created equal.

FDA-registered 503B outsourcing facilities and state-licensed 503A compounding pharmacies are required to follow manufacturing standards, test for purity and potency, and provide Certificates of Analysis. Research chemical companies are not held to these standards.

Studies have shown that peptides from unregulated sources frequently contain:

Incorrect amino acid sequences
Bacterial endotoxins
Heavy metal contamination
Significantly less (or more) active compound than labeled
Unlisted additives

Your provider should use a pharmacy that provides third-party testing and COAs for every batch. Ask to see them. If the provider can't produce documentation of peptide purity and potency, you're assuming unnecessary risk.

Building Your First Protocol: A Practical Framework

You shouldn't walk into your first appointment without understanding how protocols are structured. This knowledge helps you have a more productive conversation with your provider and spot red flags.

Start Low, Go Slow

The cardinal rule of peptide therapy — especially for beginners — is to start with the lowest effective dose and titrate up based on response and tolerance. This approach:

Minimizes side effects during the adjustment period
Allows you to identify your individual response to each compound
Makes it easier to pinpoint the cause if you experience adverse effects
Avoids the waste (and cost) of overshooting your optimal dose

A typical starter protocol for a growth hormone secretagogue like CJC-1295/Ipamorelin might begin at 100 mcg of each compound at bedtime for the first week, increasing to 200-300 mcg based on tolerance and IGF-1 response.

Cycling and Protocol Duration

Most peptide protocols aren't meant to run indefinitely without breaks. Cycling — periods of use followed by periods off — serves several purposes:

Prevents receptor desensitization — continuous stimulation of the same receptor can reduce its sensitivity over time, diminishing the peptide's effectiveness
Allows assessment — time off lets you evaluate which benefits persist and which were directly dependent on the peptide
Reduces long-term risk — less total exposure means less cumulative risk, particularly for compounds without long-term safety data

Common cycling patterns include:

5 days on, 2 days off — popular for GH secretagogues
6-12 weeks on, 4 weeks off — common for BPC-157 and TB-500 healing protocols
As-needed dosing — standard for PT-141

Your provider should explain the cycling rationale for your specific protocol. If the recommendation is "take it every day forever," that warrants a follow-up question.

Stacking: When and How to Combine Peptides

Stacking means using multiple peptides simultaneously. Some combinations are well-established in clinical practice:

BPC-157 + TB-500 — the classic healing stack, with BPC-157 targeting tissue repair and TB-500 addressing inflammation and cell migration
CJC-1295 + Ipamorelin — a synergistic GH secretagogue combination that produces more robust GH pulses than either alone
GH secretagogue + BPC-157 — combining growth hormone optimization with targeted tissue repair

But stacking has limits. More peptides doesn't automatically mean better results. Each additional compound:

Increases cost
Adds potential side effects
Makes it harder to identify what's working
Increases the complexity of your protocol

For beginners, starting with a single peptide or one well-established combination is the smartest approach. You can always add compounds later once you understand your baseline response.

Tracking Your Results

Subjective assessment alone isn't enough. Build a tracking system:

Before-and-after labs — repeat relevant bloodwork at 6-8 weeks and 3 months. IGF-1 is the primary biomarker for GH secretagogues. Inflammatory markers for healing peptides
Symptom journal — track sleep quality, energy, recovery time, pain levels, or whatever your primary goals are. Rate them on a consistent scale
Body composition — if relevant, use the same measurement method consistently (DEXA scan, body fat calipers, or even just progress photos under the same lighting)
Side effect log — note any side effects, when they occur relative to dosing, and whether they resolve

This data makes follow-up appointments dramatically more productive and helps your provider optimize your protocol based on objective information rather than vague impressions.

If you're considering peptides alongside hormone therapy, read Peptide Therapy vs TRT: Which Is Right for You for a comparison of the two approaches.

Frequently Asked Questions

How quickly will I notice results from peptide therapy? It depends entirely on the peptide and your goals. GLP-1 agonists like semaglutide can produce noticeable appetite suppression within days and measurable weight loss within 2-4 weeks. Growth hormone secretagogues typically show improved sleep quality within the first 1-2 weeks, with body composition changes becoming apparent at 8-12 weeks. Healing peptides like BPC-157 may produce noticeable pain reduction within 1-3 weeks for acute injuries, though chronic conditions take longer. Your provider should set realistic timeline expectations during your consultation.

Are peptides legal to buy and use in the United States? Yes, but with important caveats. FDA-approved peptide drugs (like semaglutide or Bremelanotide) are fully legal with a prescription. As of February 2026, 14 previously restricted peptides were reclassified to allow legal compounding by licensed pharmacies under a physician's prescription. Buying "research chemical" peptides online for personal use occupies a legal gray area — they're sold for research purposes only, and self-administering them is not endorsed by any regulatory body. The safest and most legal route is always through a licensed provider and a regulated compounding pharmacy.

Do I need to keep injecting forever, or can I stop? Most peptide protocols are designed as finite courses, not lifelong commitments. Healing protocols with BPC-157 or TB-500 typically run 6-12 weeks and stop once the therapeutic goal is met. Growth hormone secretagogues are often cycled — months on, weeks off — rather than used continuously. Some patients choose ongoing low-dose maintenance protocols, but this is a decision made with your provider based on your response and goals. Stopping peptides doesn't cause withdrawal, though some benefits may gradually diminish.

Can I use peptides if I'm already on other medications? Potentially, but this requires careful evaluation by your provider. Peptides can interact with existing medications — growth hormone secretagogues may alter insulin sensitivity (important if you're on diabetes medications), PT-141 can affect blood pressure (relevant if you're on antihypertensives), and some peptides may influence thyroid function. A complete medication review is a standard part of any responsible initial consultation. Never start peptides without disclosing every medication, supplement, and over-the-counter product you use.

What's the difference between compounded peptides and research peptides I can buy online? The difference is regulation, testing, and accountability. Compounded peptides from 503A or 503B pharmacies are produced under manufacturing standards, tested for purity and potency, and dispensed under a physician's prescription. Research peptides sold online are labeled "not for human consumption," face no manufacturing oversight, and have no guarantee of purity, potency, or even correct chemical identity. Studies have documented contamination, incorrect sequences, and wildly inconsistent dosing in research-grade products. The cost savings of research peptides are not worth the safety risk, especially for beginners without experience evaluating product quality.

Quick Answer